BOGLE INVESTMENT MANAGEMENT L P /DE/ - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 156 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$364,000
-37.5%
7,819
-42.9%
0.58%
+237.4%
Q3 2020$582,000
-95.5%
13,700
-91.4%
0.17%
-82.2%
Q2 2015$12,860,000
+136.2%
159,049
+22.4%
0.96%
+155.5%
Q1 2015$5,444,000129,9690.38%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders